Head-to-Head

GeoVax Labs, Inc. New vs. Johnson & Johnson

GOVX

GeoVax Labs, Inc. New

$0.72 +0.03%

VS JNJ

Johnson & Johnson

$260.35 -0.66%

Johnson & Johnson (JNJ) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

GOVXJNJ
Market Cap $3.74 million $627.42 billion
Revenue (TTM) — $97.93 billion
Net Income (TTM) — $21.04 billion

JNJ leads on 1 of 1 size & scale factors.

Valuation

GOVXJNJ
P/E Ratio — 30.20
Price / Book — 7.38
Price / Sales — 6.41

GOVX and JNJ split the valuation factors evenly.

Profitability

GOVXJNJ
Net Margin — 21.48%
Return on Equity — 24.76%

GOVX and JNJ split the profitability factors evenly.

Dividend

GOVXJNJ
Dividend Yield — 2.06%
Payout Ratio — 62.18

GOVX and JNJ split the dividend factors evenly.

Risk & Sentiment

GOVXJNJ
Short Interest 2.73% 0.67%

JNJ leads on 1 of 1 risk & sentiment factors.

Dig deeper: GOVX overview, GOVX financials, JNJ overview, JNJ financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.